Nu-Med Plus (NUMD) Amortization of Deferred Charges (2013 - 2014)
Nu-Med Plus' (NUMD) quarterly Amortization of Deferred Charges came in at $30716.0 in Q1 2014, down 7.62% quarter-over-quarter from $33248.0 in Q4 2013.
Nu-Med Plus (NUMD) Amortization of Deferred Charges (2013 - 2014) Analysis & Trends
Nu-Med Plus has disclosed Amortization of Deferred Charges across 2 years of filings, most recently posting $30716.0 for Q1 2014.
- Amortization of Deferred Charges for Q1 2014 came in at $30716.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2014 was $30716.0 (down 63.58% YoY), and the FY2014 annual result was $30716.0, down 63.58% from the prior year.
- Amortization of Deferred Charges came in at $30716.0 for Q1 2014 at Nu-Med Plus, down from $33248.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $51086.0 in Q3 2013 to a low of $30716.0 in Q1 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Nu-Med Plus | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2014 | 30,716.00 |
| Mar 31, 2014 | 30,716.00 |
| Dec 31, 2013 | 33,248.00 |
| Dec 31, 2013 | 33,248.00 |
| Sep 30, 2013 | 51,086.00 |
| Sep 30, 2013 | 51,086.00 |